YIELD10 BIOSCIENCE, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Yield10 Bioscience, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Yield10 Bioscience, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 150M shares, a 150% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 150M +90M +150% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 60M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 60M 0 0% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 60M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 60M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 60M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 60M 0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 60M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 60M 0 0% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 60M 0 0% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 60M 0 0% Dec 31, 2021 10-K 2023-03-14
Q3 2021 60M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 60M 0 0% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 60M 0 0% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 60M 0 0% Dec 31, 2020 10-K 2022-03-25
Q3 2020 60M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 60M 0 0% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 60M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 60M 0 0% Dec 31, 2019 10-K 2021-03-16
Q3 2019 60M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 60M 0 0% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 60M +20M +50% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 60M +20M +50% Dec 31, 2018 10-K 2020-03-25
Q3 2018 60M -190M -76% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 60M -190M -76% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 40M -210M -84% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 40M -210M -84% Dec 31, 2017 10-K 2019-03-28
Q3 2017 250M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 250M 0 0% Jun 30, 2017 10-Q/A 2017-10-06
Q1 2017 250M 0 0% Mar 31, 2017 10-Q/A 2017-10-06
Q4 2016 250M 0 0% Dec 31, 2016 10-Q 2018-11-08
Q3 2016 250M 0 0% Sep 30, 2016 10-Q 2016-11-18
Q2 2016 250M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 250M 0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 250M 0 0% Dec 31, 2015 10-K 2017-03-30
Q3 2015 250M +150M +150% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 250M +150M +150% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 250M 0 0% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 250M +150M +150% Dec 31, 2014 10-K 2016-03-29
Q3 2014 100M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 100M 0 0% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 250M +150M +150% Mar 31, 2014 10-Q 2015-05-14
Q4 2013 100M 0 0% Dec 31, 2013 10-K 2015-03-25
Q3 2013 100M 0 0% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 100M 0 0% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 100M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 100M 0 0% Dec 31, 2012 10-K 2014-03-28
Q3 2012 100M 0 0% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 100M 0 0% Jun 30, 2012 10-Q 2012-07-27
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 100M 0 0% Dec 31, 2011 10-K 2013-03-28
Q3 2011 100M Sep 30, 2011 10-Q 2011-11-02
Q2 2011 100M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 100M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.